Another recent study showed that in MFS patients, the TGFβ regulator SARA (Smad anchor for Receptor Activation) and SMAD2 is enriched within membrane fractions and leads to increased receptor interaction [64]. The gene discussed is SMAD2; the disease is Marfan syndrome.